ASP Isotopes Target of Unusually High Options Trading (NASDAQ:ASPI)

ASP Isotopes Inc. (NASDAQ:ASPI) saw unusually large options trading activity on Friday. Stock traders acquired 24,907 call options on the stock. This represents an increase of 82% compared to the average volume of 13,708 call options.

Insider Activity

In other ASP Isotopes news, CEO Robert Ainscow sold 8,438 shares of ASP Isotopes stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $6.20, for a total transaction of $52,315.60. Following the transaction, the chief executive officer directly owned 1,546,255 shares of the company’s stock, valued at approximately $9,586,781. The trade was a 0.54% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Heather Kiessling sold 80,000 shares of the firm’s stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $5.80, for a total value of $464,000.00. Following the transaction, the chief financial officer owned 732,500 shares in the company, valued at approximately $4,248,500. This trade represents a 9.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 14.40% of the company’s stock.

Institutional Trading of ASP Isotopes

Hedge funds have recently bought and sold shares of the company. ProShare Advisors LLC grew its position in shares of ASP Isotopes by 12.4% during the 3rd quarter. ProShare Advisors LLC now owns 13,101 shares of the company’s stock valued at $126,000 after acquiring an additional 1,448 shares during the period. Ameritas Investment Partners Inc. boosted its position in shares of ASP Isotopes by 41.2% during the second quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock worth $40,000 after acquiring an additional 1,600 shares during the last quarter. Mercer Global Advisors Inc. ADV increased its holdings in ASP Isotopes by 8.3% in the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 21,056 shares of the company’s stock valued at $203,000 after acquiring an additional 1,622 shares during the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of ASP Isotopes by 9.9% in the second quarter. The Manufacturers Life Insurance Company now owns 20,840 shares of the company’s stock worth $153,000 after purchasing an additional 1,878 shares during the last quarter. Finally, Legal & General Group Plc lifted its position in shares of ASP Isotopes by 30.4% in the third quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock worth $81,000 after buying an additional 1,953 shares in the last quarter. Hedge funds and other institutional investors own 16.80% of the company’s stock.

ASP Isotopes Price Performance

Shares of NASDAQ ASPI traded up $0.29 during mid-day trading on Friday, reaching $5.40. 4,477,184 shares of the company were exchanged, compared to its average volume of 5,202,362. ASP Isotopes has a 52 week low of $3.71 and a 52 week high of $14.49. The company’s 50 day moving average price is $6.22 and its 200 day moving average price is $7.72. The stock has a market capitalization of $598.54 million, a PE ratio of -4.15 and a beta of 3.55. The company has a quick ratio of 6.10, a current ratio of 6.14 and a debt-to-equity ratio of 1.04.

Analyst Ratings Changes

A number of analysts recently commented on the company. Canaccord Genuity Group reaffirmed a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a research report on Monday, November 24th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, December 29th. Finally, Cantor Fitzgerald started coverage on shares of ASP Isotopes in a report on Thursday, December 4th. They issued an “overweight” rating and a $13.00 price target on the stock. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $13.00.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.